All News
Filter News
Found 806,238 articles
-
Zoetis to Host Webcast and Conference Call on First Quarter 2021 Financial Results
3/31/2021
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 6, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review first quarter 2021 financial results and respond to questions from financial analysts during the call.
-
Ascentage Pharma Announces 2020 Annual Results and Reports Launch Readiness for Its Core Drug Candidate
3/31/2021
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for full year 2020, during which the company continued its rapid growth, despite the enormous challenges posed by the COVID-19 pandemic
-
Vesta Pioneers New Depths of Online Community Insights with Launch of Applied Consumer Neuroscience Research
3/31/2021
Vesta, the leader in Community Powered Marketing, announced the launch of their new Applied Consumer Neuroscience suite of tools to seamlessly deliver deeper consumer intelligence from its online community software.
-
Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021
3/31/2021
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will report full year 2020 financial results on Tuesday, April 6, 2021,
-
Moderna to Host Second Annual Virtual Vaccines Day on April 14, 2021
3/31/2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Wednesday, April 14.
-
Boundless Bio Announces Upcoming Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
3/31/2021
Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced plans to present at the American Association for Cancer Research (AACR) Annual Meeting 2021, held virtually from April 10-15, 2021.
-
NexImmune Reports Fiscal Year 2020 Financial Results and Recent Updates
3/31/2021
NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today reported its financial results for 2020 and highlighted recent corporate accomplishments
-
Atalanta Therapeutics to Present at Stifel 3rd Annual CNS Day
3/31/2021
Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, announced today that Alicia Secor, president and chief executive officer, and Aimee L. Jackson, Ph.D., chief scientific officer, are scheduled to participate virtually in an analyst-led fireside chat at the Stifel 3rd Annual CNS Day on Thursday, April 1, 2021 at 1:30 pm ET.
-
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
3/31/2021
Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced financial results and for the year ended December 31, 2020 and provided an update on recent corporate highlights.
-
International Isotopes Inc. Announces 2020 Year End Financial Results
3/31/2021
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2020.
-
Actinium to Participate in the Cell &Gene Meeting on the Mediterranean
3/31/2021
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it will be participating in the Cell & Gene Meeting on the Mediterranean, which is being held virtually April 6 – 9, 2021,
-
AIM ImmunoTech Reports 2020 Year-End Financial Results
3/31/2021
AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the fiscal year ended December 31, 2020 and provides a business update.
-
Biorem Reports $2.1 million Earnings for Fiscal 2020
3/31/2021
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2020.
-
Micron Solutions, Inc. Reports 2020 Fourth Quarter and Year End Results
3/31/2021
Micron Solutions, Inc. (OTCQB: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, Inc., producing highly-engineered, innovative components requiring precision machining and injection molding, announced results for its fourth quarter and year ended December 31, 2020.
-
Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K
3/31/2021
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2020 with the Securities and Exchange Commission ("SEC").
-
ESCAPE Bio to Present at Stifel’s 3rd Annual CNS Day
3/31/2021
ESCAPE Bio Inc., a clinical stage company developing novel, precisely targeted therapeutics for genetic neurodegenerative diseases, today announced that Paul Wren, Ph.D., Chief Scientific Officer of ESCAPE Bio, will participate in a fireside chat at Stifel’s 3rd Annual CNS Day on Thursday, April 1, 2021, at 3:30 p.m. ET
-
CTI BioPharma Corp. Announces Proposed Public Offering of Common Stock and Preferred Stock
3/31/2021
CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers, today announced that it intends to offer and sell shares of its common stock and series X1 preferred stock
-
Eisai And Advocacy Leaders Team Up To Launch Spot Her - An Initiative That Empowers Women To Help Spot The Signs Of Endometrial Cancer
3/31/2021
Eisai Inc. announced today the launch of Spot Her—an initiative to end the silence around endometrial cancer, a type of uterine cancer, and inspire women to listen, advocate and put their health and the health of other women first.
-
Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance
3/31/2021
The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo!
-
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
3/31/2021
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the fourth quarter and the full year ended December 31, 2020.